D.E. Shaw & Co’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-29,900
Closed -$1.77M 5602
2021
Q4
$1.77M Sell
29,900
-10,000
-25% -$692K ﹤0.01% 3464
2021
Q3
$2.65M Sell
39,900
-10,000
-20% -$617K ﹤0.01% 2752
2021
Q2
$3.15M Buy
49,900
+29,900
+150% +$1.68M ﹤0.01% 2473
2021
Q1
$1.04M Buy
+20,000
New +$1.22M ﹤0.01% 3081

Other funds holding CYRX

D.E. Shaw & Co's CYRX Position: Q1 2026 in Review

D.E. Shaw & Co reduced its CryoPort (CYRX) stake by 37% in Q1 2026, selling an estimated $823K and leaving 158,225 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #3239.

D.E. Shaw & Co first reported a position in CYRX in Q3 2018 and has held it in 24 quarters since. The position peaked at $19.5M in Q3 2020. 165 funds tracked by Wall St. Rank hold CYRX as of Q1 2026.

  • D.E. Shaw & Co held 158,225 shares of CryoPort worth $1.31M as of Q1 2026.
  • D.E. Shaw & Co sold 91,078 CryoPort shares in Q1 2026, an estimated $823K.
  • CryoPort made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3239 holding.
  • D.E. Shaw & Co first reported a position in CryoPort in Q3 2018 and has held it in 24 quarters since.
  • D.E. Shaw & Co's CryoPort position peaked at $19.5M in Q3 2020.
  • 165 funds tracked by Wall St. Rank held CryoPort as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.